ODDB.org: Open Drug Database | Drugs

|

|

|

|

|

|

Registration owner

|

Search result - 68221 - 01

Sanofi-Aventis (Suisse) SA - MenQuadfi, solution injectable

Swissmedic Registration	68221	Sequence	01
Product name	MenQuadfi	Description	solution injectable
ATC-Classification	J07AH08	ATC-Description	Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated
Introduction of Sequence	05.10.2022

Composition

polysaccharida neisseriae meningitidis A 10 µg et polysaccharida neisseriae meningitidis C 10 µg et polysaccharida neisseriae meningitidis Y 10 µg et polysaccharida neisseriae meningitidis W-135 10 µg conjugatum cum toxoidum tetani 55 µg, natrii chloridum, natrii acetas ut natrii acetas trihydricus et acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.67 mg.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Conjugatum cum Toxoidum Tetani	55µg / 0.5ml
Polysaccharida Neisseriae Meningitidis A	10µg / 0.5ml
Polysaccharida Neisseriae Meningitidis C	10µg / 0.5ml
Polysaccharida Neisseriae Meningitidis Y	10µg / 0.5ml

BAG: Active Agent	Dose
Polysaccharida Neisseriae Meningitidis A	10 mcg
Polysaccharida Neisseriae Meningitidis C	10 mcg
Polysaccharida Neisseriae Meningitidis W-135	10 mcg
Polysaccharida Neisseriae Meningitidis Y	10 mcg
Vaccinum Meningitidis Polysaccharid. Tetravalens A, C, W135, y Conjugatum T

Inactive agents	Dose
Acidum Aceticum Glaciale
Sodium Acetate
Sodium Chloride
Polysaccharida Neisseriae Meningitidis W-135	10µg / 0.5ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		41.15	61.15	B	SL	Yes

2025	©ywesee GmbH

|

|

|

|

|